NeuBase Therapeutics
Ranajoy Sarkar, PhD, MBA, possesses extensive experience in business development, strategy, and alliance management within the biotechnology and pharmaceutical sectors. Currently serving in a leadership role at Pin Therapeutics, Inc., Ranajoy previously held significant positions at NeuBase Therapeutics, Inc., where responsibilities included corporate strategy development and end-to-end business development activities. Prior experience includes leadership at PineTree Therapeutics Inc., Assembly Biosciences, Inc., and Allergan, with a focus on driving growth, strategic partnerships, and managing clinical and product development. Educational qualifications include an MBA from The Wharton School and a PhD in Pharmaceutics and Drug Design from The University of Georgia.
This person is not in any teams
This person is not in any offices
NeuBase Therapeutics
NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines that can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease.